TY - JOUR
T1 - Diagnostic Performance of 2D Shear Wave (2D-SWE) for Liver Fibrosis in Adults Undergoing Bariatric Surgery
AU - Alcantara-Diaz, Ana L.
AU - Ruiz-Fernandez, Jaime F.
AU - Salazar-Alarcon, Jorge L.
AU - Salinas-Sedo, Gustavo
AU - Toro-Huamanchumo, Carlos J.
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023/8/11
Y1 - 2023/8/11
N2 - Background: Among the most recent methods to diagnose liver fibrosis is 2D shear wave elastography (2D-SWE). However, the evidence in the Latin population is limited, and there is no consensus on the cutoff points for each stage of fibrosis. Aim: To evaluate the diagnostic performance of 2D-SWE for liver fibrosis in adults with obesity who underwent bariatric surgery (BS). Methods: We conducted a cross-sectional study on patients with obesity who underwent BS between 2020 and 2021. Liver stiffness measurement was reported as the mean of valid measurements in kilopascals made with the 2D-SWE. The outcome was biopsy-proven liver fibrosis. ROC curves were constructed for significant fibrosis (F≥2) and advanced fibrosis (F≥3), with their respective area under the curve (AUC). To obtain the best cutoff point for each scenario, we used the Youden index. The 95% confidence intervals (95% CI) for each cutoff point were estimated by bootstrap with 1000 replications. Results: We analyzed data from 227 patients. The mean age was 37.8 ± 11.1 years and 65.2% were women. Overall, the AUC for significant and advanced fibrosis was 0.54 (95% CI: 0.47–0.62) and 0.73 (95% CI: 0.60–0.87), respectively. For advanced fibrosis, higher AUCs were found among women (AUC: 0.82; 95% CI: 0.59–1.00) and among patients with morbid obesity (AUC: 0.78; 95% CI: 0.61–0.99). Conclusion: The 2D-SWE appears to be a valuable tool for screening advanced liver fibrosis in candidates for BS, mainly in the female population and in adults with morbid obesity. Graphical Abstract: [Figure not available: see fulltext.]
AB - Background: Among the most recent methods to diagnose liver fibrosis is 2D shear wave elastography (2D-SWE). However, the evidence in the Latin population is limited, and there is no consensus on the cutoff points for each stage of fibrosis. Aim: To evaluate the diagnostic performance of 2D-SWE for liver fibrosis in adults with obesity who underwent bariatric surgery (BS). Methods: We conducted a cross-sectional study on patients with obesity who underwent BS between 2020 and 2021. Liver stiffness measurement was reported as the mean of valid measurements in kilopascals made with the 2D-SWE. The outcome was biopsy-proven liver fibrosis. ROC curves were constructed for significant fibrosis (F≥2) and advanced fibrosis (F≥3), with their respective area under the curve (AUC). To obtain the best cutoff point for each scenario, we used the Youden index. The 95% confidence intervals (95% CI) for each cutoff point were estimated by bootstrap with 1000 replications. Results: We analyzed data from 227 patients. The mean age was 37.8 ± 11.1 years and 65.2% were women. Overall, the AUC for significant and advanced fibrosis was 0.54 (95% CI: 0.47–0.62) and 0.73 (95% CI: 0.60–0.87), respectively. For advanced fibrosis, higher AUCs were found among women (AUC: 0.82; 95% CI: 0.59–1.00) and among patients with morbid obesity (AUC: 0.78; 95% CI: 0.61–0.99). Conclusion: The 2D-SWE appears to be a valuable tool for screening advanced liver fibrosis in candidates for BS, mainly in the female population and in adults with morbid obesity. Graphical Abstract: [Figure not available: see fulltext.]
KW - Bariatric surgery
KW - Elasticity imaging techniques
KW - Fibrosis
KW - Liver
KW - Bariatric Surgery
KW - Cross-Sectional Studies
KW - Liver Cirrhosis/diagnostic imaging
KW - Elasticity Imaging Techniques/methods
KW - Humans
KW - Middle Aged
KW - Male
KW - Obesity, Morbid/surgery
KW - Adult
KW - Female
KW - ROC Curve
KW - Liver/diagnostic imaging
UR - http://www.scopus.com/inward/record.url?scp=85167687499&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/4e99d1bb-f9fa-39f8-bc69-06ec58a3d851/
U2 - 10.1007/s11695-023-06766-1
DO - 10.1007/s11695-023-06766-1
M3 - Artículo
C2 - 37566340
AN - SCOPUS:85167687499
SN - 0960-8923
VL - 33
SP - 3120
EP - 3126
JO - Obesity Surgery
JF - Obesity Surgery
IS - 10
ER -